Blueberries Medical Corp. (BBRRF) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
Market cap $5.94M is the value of all shares combined. Beta 2.65: the stock has moved about 165% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerBlueberries Medical Corp. (BBRRF) trades at $0.012. Blueberries Medical Corp. is a Colombia-based company focused on the cultivation, production, and supply of medicinal cannabis. Market cap: $5.94M, Sector: Healthcare.
Price as of Sep 11, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for BBRRF: BBRRF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates BBRRF against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
These figures come from statements filed 12 months ago — the most recent this company has published.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
BBRRF: the 2 scored disciplines are evenly split. Dominant signal: Seth Klarman bearish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Blueberries Medical Corp. (BBRRF) Healthcare & Pipeline Overview
Blueberries Medical Corp. cultivates, develops, and supplies medicinal cannabis products in Colombia, targeting the growing Latin American market. The company offers medicinal-grade cannabis oil extracts, but faces challenges related to profitability and regulatory landscapes in the evolving cannabis industry. It trades on the OTC market.
What Is the Investment Thesis for BBRRF?
Blueberries Medical Corp. presents a high-risk, high-reward investment opportunity within the emerging Latin American cannabis market. The company's focus on medicinal-grade cannabis oil extracts positions it to capitalize on the growing demand for alternative therapies. However, the company's negative profit margin of -375.4% and OTC listing indicate significant financial and operational challenges. Growth catalysts include expanding distribution networks and securing regulatory approvals in new markets. Key risks include intense competition, evolving regulations, and the company's ability to achieve profitability. Investors should carefully consider the company's financial position, market dynamics, and regulatory environment before investing.
Based on FMP financials and quantitative analysis
BBRRF Key Highlights
Market Cap of $5.94M reflects the company's small size and speculative nature.
- P/E Ratio of -3.19 indicates the company is currently not profitable.
- Gross Margin of 31.0% suggests potential for profitability if operating expenses are managed effectively.
- Beta of 2.65 indicates high volatility compared to the overall market.
- The company does not currently pay a dividend, reflecting its focus on reinvesting earnings for growth.
Who Are BBRRF's Competitors?
BBRRF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| AVTBF Avant Brands Inc. | $0.42 | -4.08% | $6.35M | — |
| CPIVF Captiva Verde Wellness Corp. | $0.06 | -20.55% | $17.7M | — |
| MVMDF Mountain Valley MD Holdings Inc. | $0.05 | -14.52% | $16.6M | — |
| AVCNF Avicanna Inc. | $0.08 | 0.00% | $10.6M | 529-signal |
| PLNH Planet 13 Holdings Inc. | $0.13 | -7.14% | $42.7M | 429-signal |
| DBCCF Decibel Cannabis Company Inc. | $1.27 | -3.39% | $49.0M | 459-signal |
| ZYBT Zhengye Biotechnology Holding Limited | $1.59 | +1.27% | $75.4M | 465-pillar |
| CWBHF Charlotte's Web Holdings, Inc. | $0.33 | -3.93% | $88.4M | 519-signal |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are BBRRF's Key Strengths?
Presence in the emerging Latin American cannabis market.
- Focus on medicinal-grade cannabis oil extracts.
- Vertically integrated operations from cultivation to production.
- Experienced management team with expertise in cannabis cultivation and extraction.
What Are BBRRF's Weaknesses?
Negative profit margin and limited financial resources.
- Dependence on regulatory approvals and market access.
- Intense competition from established cannabis producers.
- OTC listing indicates higher risk and lower liquidity.
What Could Drive BBRRF Stock Higher?
Expansion into new Latin American markets, driving revenue growth.
- Development of new cannabis-based products targeting specific medical conditions.
- Strategic partnerships with healthcare providers to promote the use of medicinal cannabis products.
- Securing regulatory approvals in key markets, such as Colombia and other Latin American countries.
- Improving production efficiency and reducing costs through investments in technology and process optimization.
What Are the Key Risks for BBRRF?
Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Evolving regulations and uncertainty in the cannabis industry.
- Price competition from low-cost producers.
- Potential for oversupply in the cannabis market.
- Negative public perception of cannabis.
- Limited financial resources and negative profit margin.
What Are the Growth Opportunities for BBRRF?
- Expansion into New Latin American Markets: Blueberries Medical can pursue growth by expanding its operations into other Latin American countries with favorable cannabis regulations. The Latin American cannabis market is projected to experience significant growth in the coming years, offering substantial opportunities for companies with a strong regional presence. Timeline: Ongoing, with potential for significant expansion within the next 3-5 years.
- Development of New Cannabis-Based Products: Blueberries Medical can invest in research and development to create new cannabis-based products targeting specific medical conditions. This could include formulations for pain management, anxiety, and sleep disorders. The market for specialized cannabis products is growing rapidly, driven by increasing demand for alternative therapies. Timeline: Ongoing, with new product launches expected within the next 1-2 years.
- Strategic Partnerships with Healthcare Providers: Blueberries Medical can establish strategic partnerships with healthcare providers to promote the use of its medicinal cannabis products. This could involve educating doctors and other healthcare professionals about the benefits of cannabis-based treatments. The healthcare provider channel represents a significant opportunity for reaching patients and increasing sales. Timeline: Ongoing, with partnerships expected to expand within the next 1-3 years.
- Securing Regulatory Approvals in Key Markets: Blueberries Medical can focus on securing regulatory approvals for its products in key markets, such as Colombia and other Latin American countries. Regulatory approvals are essential for accessing these markets and establishing a competitive advantage. Timeline: Ongoing, with approvals expected to be secured within the next 1-2 years.
- Improving Production Efficiency and Reducing Costs: Blueberries Medical can improve its production efficiency and reduce costs through investments in technology and process optimization. This would improve the company's profitability and competitiveness. The cannabis industry is becoming increasingly competitive, making cost efficiency a critical success factor. Timeline: Ongoing, with continuous improvements expected over the next several years.
What Are BBRRF's Competitive Advantages?
- First-mover advantage in the Colombian medicinal cannabis market.
- Proprietary cultivation and extraction techniques.
- Established relationships with healthcare providers and pharmacies.
- Brand recognition in the Latin American market.
What Does BBRRF Do?
Blueberries Medical Corp., headquartered in Bogotá, Colombia, is a medicinal cannabis company focused on the growth, cultivation, development, production, and supply of medicinal cannabis and related products. The company aims to capitalize on the burgeoning medicinal cannabis market in Latin America, particularly in Colombia, where regulations have created opportunities for licensed producers. Blueberries Medical offers medicinal-grade cannabis oil extracts and related products, targeting patients and healthcare providers seeking alternative treatment options. The company's operations encompass the entire value chain, from cultivation to extraction and product formulation. Blueberries Medical aims to establish a strong presence in the Colombian market and expand its reach to other Latin American countries as regulations evolve. The company faces competition from both local and international cannabis producers, as well as challenges related to regulatory compliance, market access, and pricing pressures. Blueberries Medical trades on the OTC market under the ticker symbol BBRRF.
What Products and Services Does BBRRF Offer?
- Cultivates medicinal cannabis plants in Colombia.
- Develops medicinal-grade cannabis oil extracts.
- Produces a range of cannabis-related products.
- Supplies medicinal cannabis products to patients and healthcare providers.
- Focuses on the Latin American market.
- Operates throughout the entire cannabis value chain, from cultivation to product formulation.
How Does BBRRF Make Money?
- Cultivation and production of medicinal cannabis.
- Sales of cannabis oil extracts and related products.
- Distribution through pharmacies and healthcare providers.
- Revenue generation through product sales in the Colombian and Latin American markets.
What Industry Does BBRRF Operate In?
Blueberries Medical Corp. operates in the rapidly evolving medicinal cannabis industry, which is experiencing significant growth and regulatory changes. The competitive landscape includes established pharmaceutical companies, specialized cannabis producers, and emerging startups. Blueberries Medical is positioned within the Latin American market, which offers unique opportunities and challenges due to varying regulatory frameworks and market dynamics. Competitors include AVTBF (Avanti Health Technologies Inc.), CANN (Cronos Group Inc.), CPIVF (Canopy Pacific Inc.), IONKF (Isracann Biosciences Inc.), and MVMDF (MediPharm Labs Corp.).
Who Are BBRRF's Key Customers?
- Patients seeking alternative treatments for various medical conditions.
- Healthcare providers recommending or prescribing medicinal cannabis.
- Pharmacies and dispensaries selling cannabis products.
- Research institutions conducting studies on medicinal cannabis.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
- ● Reported in CAD, converted to USD
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 59 |
| 2026-08-26 | 59 |
| 2026-08-29 | 59 |
| 2026-09-01 | 59 |
| 2026-09-04 | 59 |
| 2026-09-07 | 59 |
| 2026-09-10 | 59 |
What changed?
The score has stayed at 59.
Over the same 18 days the stock moved -9.9%.
Company Profile
Blueberries Medical Corp. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Vancouver, CA. The company is led by CEO Facundo Garreton. BBRRF has traded publicly since 2019.
Blueberries Medical Corp. Financial Trajectory
Blueberries Medical Corp. (BBRRF) reported $25K in revenue for Jun 2026, a decline of 18.0% compared to the prior quarter. The company recorded a net loss of $149K, with diluted EPS of $-0.00. Revenue has contracted over three consecutive quarters, which investors in this micro-cap Healthcare stock should monitor closely. Across the four most recent quarters, BBRRF averaged $-0.00 in diluted EPS.
How Blueberries Medical Corp. Is Valued
Blueberries Medical Corp. carries a market capitalization of $5.94M, placing it in the micro-cap category.
Key Financial Metrics
Its free cash flow yield is -8.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.62 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -21.4%, the inverse of the P/E and a quick read on earnings relative to price.
Financial Health
Blueberries Medical Corp.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
BBRRF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Presence in the emerging Latin American cannabis market.
- Focus on medicinal-grade cannabis oil extracts.
- Vertically integrated operations from cultivation to production.
- Experienced management team with expertise in cannabis cultivation and extraction.
Bear Case
- Negative profit margin and limited financial resources.
- Dependence on regulatory approvals and market access.
- Intense competition from established cannabis producers.
- OTC listing indicates higher risk and lower liquidity.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Jun 2026 | $25,324.33 | -$148,927.537 | -$0.0003 |
| Mar 2026 | $30,895.394 | -$121,787.528 | -$0.0002 |
| Dec 2025 | $117,859.084 | -$358,959.393 | -$0.0007 |
| Sep 2025 | $25,677.659 | -$136,535.056 | -$0.0003 |
Based on FMP financials and quantitative analysis · Converted to USD from CAD at today's rate
BBRRF Latest News
-
Blueberries Medical Announces Closing of C$1.1 Million Non-Brokered Private Placement
accessnewswire.com · Aug 26, 2026
-
Blueberries Medical Announces C$1.1 Million Non-Brokered Private Placement
accessnewswire.com · Jul 29, 2026
-
Washington Post Reported President Trump Expected To Announce A Medicare Pilot Program To Reimburse Patients' CBD Treatments
benzinga · Dec 18, 2025
-
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report
benzinga · Dec 17, 2025
BBRRF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for BBRRF.
Price Targets
Wall Street price target analysis for BBRRF.
BBRRF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for BBRRF; grades run from A+ (80-100) to F (below 30).
Latest News
Blueberries Medical Announces Closing of C$1.1 Million Non-Brokered Private Placement
Blueberries Medical Announces C$1.1 Million Non-Brokered Private Placement
Washington Post Reported President Trump Expected To Announce A Medicare Pilot Program To Reimburse Patients' CBD Treatments
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report
Leadership: Facundo Garreton
CEO
Facundo Garreton is the CEO of Blueberries Medical Corp. His background includes experience in the pharmaceutical and agricultural industries. He has a proven track record of leading and growing companies in emerging markets. Garreton's expertise in regulatory affairs and market access is crucial for navigating the complex cannabis industry landscape. He holds a degree in Business Administration from a leading university.
Track Record: Under Facundo Garreton's leadership, Blueberries Medical Corp. has expanded its operations in Colombia and developed a portfolio of medicinal cannabis products. He has focused on securing regulatory approvals and establishing partnerships with healthcare providers. Garreton has also overseen the company's efforts to improve production efficiency and reduce costs.
BBRRF OTC Market Information
The OTC Other tier, where Blueberries Medical Corp. trades, represents the lowest tier of the OTC market. Companies in this tier often have limited financial disclosure, do not meet minimum listing standards, and may be subject to greater risks of fraud or manipulation compared to companies listed on major exchanges like the NYSE or NASDAQ. These companies may not be required to file reports with the SEC, leading to less transparency for investors. Investing in OTC Other stocks requires a higher degree of due diligence and risk tolerance.
- OTC Tier: OTC Other
- Limited financial disclosure and transparency.
- Higher risk of fraud or manipulation.
- Lower trading volumes and liquidity.
- Greater price volatility.
- Potential for delisting or suspension of trading.
- Verify the company's financial statements and audit reports.
- Research the background and experience of the management team.
- Assess the company's regulatory compliance and legal standing.
- Evaluate the company's competitive position and market outlook.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Confirm the legitimacy of the company's operations and assets.
- Licensed to cultivate and produce medicinal cannabis in Colombia.
- Partnerships with healthcare providers and pharmacies.
- Presence in the Latin American market.
- Experienced management team with expertise in the cannabis industry.
BBRRF Healthcare Stock FAQ
Is BBRRF a good stock?
Stock Expert AI does not rate BBRRF buy, sell or hold. Blueberries Medical Corp. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What do analysts say about BBRRF stock?
As an OTC-listed company with a small market capitalization, Blueberries Medical Corp. (BBRRF) may not be widely covered by analysts.
What are the key factors to evaluate for BBRRF?
Evaluate BBRRF on fundamentals, analyst consensus, and risk factors. Market Cap of $5.94M reflects the company's small size and speculative nature. Not financial advice.
How frequently does BBRRF data refresh on this page?
BBRRF's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven BBRRF's recent stock price performance?
Blueberries Medical Corp. (BBRRF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Presence in the emerging Latin American cannabis market. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider BBRRF overvalued or undervalued right now?
Blueberries Medical Corp. (BBRRF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of BBRRF?
Yes, most major brokerages offer fractional shares of Blueberries Medical Corp. (BBRRF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track BBRRF's earnings and financial reports?
Blueberries Medical Corp. (BBRRF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for BBRRF earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available company filings and news sources.
- OTC market data may be less reliable than major exchange data.